TEMBEXA Trademark

Trademark Overview

On Wednesday, August 7, 2024, a trademark application was filed for TEMBEXA with the United States Patent and Trademark Office. The USPTO has given the TEMBEXA trademark a serial number of 98687461. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, August 7, 2024. This trademark is owned by Emergent Biodefense Operations Lansing LLC. The TEMBEXA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating viral infections and diseases; antiviral drugs for medical purposes; therapeutic drugs and agents for treating viral infections and diseases; therapeutic formulations for treating viral infections and diseases; antivirals; pharmaceutical preparations in the nature of anti-viral therapies; antiviral pills for pharmaceutical purposes; antiviral medicines for human purposes; Pharmaceutical preparations for the prevention of infections caused by DNA viruses; drugs for medical purposes, namely, anti-infectives; therapeutic drugs and agents, namely, lipid conjugates; therapeutic formulations for treating viral infections and diseases, namely, antivirals and anti-viral therapies
tembexa

General Information

Serial Number98687461
Word MarkTEMBEXA
Filing DateWednesday, August 7, 2024
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateWednesday, August 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of the word TEMBEXA with the "X" in an exaggerated format.
Goods and ServicesPharmaceutical preparations for treating viral infections and diseases; antiviral drugs for medical purposes; therapeutic drugs and agents for treating viral infections and diseases; therapeutic formulations for treating viral infections and diseases; antivirals; pharmaceutical preparations in the nature of anti-viral therapies; antiviral pills for pharmaceutical purposes; antiviral medicines for human purposes; Pharmaceutical preparations for the prevention of infections caused by DNA viruses; drugs for medical purposes, namely, anti-infectives; therapeutic drugs and agents, namely, lipid conjugates; therapeutic formulations for treating viral infections and diseases, namely, antivirals and anti-viral therapies
Indication of Colors claimedThe color(s) purple is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 7, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEmergent Biodefense Operations Lansing LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLansing, MI 48906

Trademark Events

Event DateEvent Description
Wednesday, February 5, 2025TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
Wednesday, February 5, 2025TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, August 7, 2024NEW APPLICATION ENTERED

Related Keywords

tembexa viral infections drugs therapeutic pharmaceutical diseases treating purposes anti antiviral